+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Cardiovascular risk reduction in high-risk pediatric populations



Cardiovascular risk reduction in high-risk pediatric populations



Pediatrics 119(3): 618-621




(PDF emailed within 0-6 h: $19.90)

Accession: 048450101

Download citation: RISBibTeXText

PMID: 17332217

DOI: 10.1542/peds.2006-3557


Related references

Cardiovascular morbidity and mortality in high-risk populations: epidemiology and opportunities for risk reduction. Journal of Clinical Hypertension 9(11 Suppl 4): 11-15, 2007

Cardiovascular risk reduction in high-risk pediatric patients - A scientific statement from the American Heart Association Expert Panel on Population and Prevention Science; the Councils on Cardiovascular Disease in the young, Epidemiology and Prevention, Nutrition, Physical Activity and Metabolism, High Blood Pressure Research, Cardiovascular Nursing, and the Kidney in Heart Disease; and the Interdisciplinary Working Group on Quality of Care and Outcomes Research. Circulation 114(24): 2710-2738, 2006

Impact of elevated cystatin C level on cardiovascular disease risk in predominantly high cardiovascular risk populations: a meta-analysis. Circulation. Cardiovascular Quality and Outcomes 3(6): 675-683, 2011

High urinary levels of resveratrol metabolites are associated with a reduction in the prevalence of cardiovascular risk factors in high-risk patients. Pharmacological Research 65(6): 615-620, 2012

Obesity, ultrasound indexes of fat depots and lipid goal attainment in patients with high and very high cardiovascular risk: A novel approach towards better risk reduction. Nutrition, Metabolism, and Cardiovascular Diseases 26(2): 123-133, 2016

The selection of high-risk patients: the objective of reduction of cardiovascular risk. Atencion Primaria 30(1): 70; Author Reply 70, 2002

Epicardial adipose tissue: new parameter for cardiovascular risk assessment in high risk populations. Journal of Nephrology 31(6): 847-853, 2018

Multifactor cardiovascular disease risk reduction in medically underserved, high-risk patients. American Journal of Cardiology 98(11): 1472-1479, 2006

Outcomes of a risk-reduction intervention with high-risk populations: the Harlem AIDS project. Aids Education and Prevention 7(5): 379-390, 1995

Obesity and Cardiovascular Diseases in a High-Risk Population: Evidence-Based Approach to CHD Risk Reduction. Ethnicity and Disease 25(2): 208-213, 2015

Improving outcomes in high-risk populations using REACH: an inpatient cardiac risk reduction program. Critical Pathways in Cardiology 8(3): 112-118, 2009

Microalbuminuria, cardiovascular risk factors, and insulin resistance in two populations with a high risk of type 2 diabetes mellitus. Diabetic Medicine 13(5): 441-449, 1996

The clinical effect and tolerability of ezetimibe in high-risk patients managed in a specialty cardiovascular risk reduction clinic. Canadian Journal of Cardiology 22(11): 939-945, 2006

Undertreatment of dyslipidemia in peripheral arterial disease and other high-risk populations: an opportunity for cardiovascular disease reduction. Vascular Medicine 7(4): 323-331, 2003

Exploring prognostic factors for achieving global cardiovascular risk reduction in high-risk patients with dyslipidemia and cardiometabolic syndrome on pharmacotherapy. 2007